Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1993 1
1994 1
1995 13
1996 30
1997 44
1998 32
1999 46
2000 52
2001 62
2002 77
2003 68
2004 77
2005 75
2006 106
2007 103
2008 85
2009 113
2010 104
2011 124
2012 134
2013 150
2014 142
2015 128
2016 138
2017 141
2018 170
2019 154
2020 213
2021 196
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

2,520 results
Results by year
Filters applied: . Clear all
Page 1
Meloxicam.
Khalil NY, Aldosari KF. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197. doi: 10.1016/bs.podrm.2019.10.006. Epub 2019 Dec 12. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164967
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a nonsteroidal anti-inflammatory drug (NSAID). ...It may also be given by rectal suppository in doses similar to those used orally. The reported
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a no
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster JY. Cooper C, et al. Drugs Aging. 2019 Apr;36(Suppl 1):15-24. doi: 10.1007/s40266-019-00660-1. Drugs Aging. 2019. PMID: 31073921 Free PMC article. Review.
An increased risk of acute myocardial infarction and heart failure is observed with all NSAIDs, while an elevated risk of hemorrhagic stroke appears to be restricted to the use of diclofenac and meloxicam. All NSAIDs have the potential to induce acute kidney injury, and pa …
An increased risk of acute myocardial infarction and heart failure is observed with all NSAIDs, while an elevated risk of hemorrhagic stroke …
Clinical evaluation of postoperative analgesia, cardiorespiratory parameters and changes in liver and renal function tests of paracetamol compared to meloxicam and carprofen in dogs undergoing ovariohysterectomy.
Hernández-Avalos I, Valverde A, Ibancovichi-Camarillo JA, Sánchez-Aparicio P, Recillas-Morales S, Osorio-Avalos J, Rodríguez-Velázquez D, Miranda-Cortés AE. Hernández-Avalos I, et al. PLoS One. 2020 Feb 14;15(2):e0223697. doi: 10.1371/journal.pone.0223697. eCollection 2020. PLoS One. 2020. PMID: 32059002 Free PMC article.
This study compared the serum biochemical changes and postoperative analgesic effects of paracetamol, meloxicam, and carprofen in bitches submitted to an ovariohysterectomy using the Dynamic Interactive Visual Analog Scale (DIVAS) and Pain Scale of the University of Melbou …
This study compared the serum biochemical changes and postoperative analgesic effects of paracetamol, meloxicam, and carprofen in bit …
Comparing paracetamol/codeine and meloxicam for postoperative analgesia in dogs: a non-inferiority trial.
Pacheco M, Knowles TG, Hunt J, Slingsby LS, Taylor PM, Murrell JC. Pacheco M, et al. Vet Rec. 2020 Oct 17;187(8):e61. doi: 10.1136/vr.105487. Epub 2020 Jan 3. Vet Rec. 2020. PMID: 31900324
METHODS: Prospective, randomised, blinded, positive-controlled clinical trial with 70 dogs (paracetamol/codeine, n=46; meloxicam, n=24) undergoing surgery. Drugs were administered orally 2 hours before and for 48 hours after surgery at the licensed dose. ...CONCLUSIONS: Pa …
METHODS: Prospective, randomised, blinded, positive-controlled clinical trial with 70 dogs (paracetamol/codeine, n=46; meloxicam, n=2 …
HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study.
Viscusi E, Minkowitz H, Winkle P, Ramamoorthy S, Hu J, Singla N. Viscusi E, et al. Hernia. 2019 Dec;23(6):1071-1080. doi: 10.1007/s10029-019-02023-6. Epub 2019 Aug 19. Hernia. 2019. PMID: 31429023 Free PMC article. Clinical Trial.
The purpose of the study was to assess the safety and efficacy of HTX-011 (bupivacaine and meloxicam in Biochronomer() polymer technology), a long-acting investigational anesthetic, in reducing both postoperative pain over 72 h and postoperative opioid use compared to bupi …
The purpose of the study was to assess the safety and efficacy of HTX-011 (bupivacaine and meloxicam in Biochronomer() polymer techno …
[Meloxicam in Russia: 20 years together].
Karateev AE, Nasonov EN. Karateev AE, et al. Ter Arkh. 2016;88(12):149-158. doi: 10.17116/terarkh20168812149-158. Ter Arkh. 2016. PMID: 28635891 Review. Russian.
Meloxicam is one of the most commonly used representatives of the group of nonsteroidal anti-inflammatory drugs prescribed in our country. ...This review briefly gives the data of Russian and main foreign clinical trials of the therapeutic effect and safety of meloxicam
Meloxicam is one of the most commonly used representatives of the group of nonsteroidal anti-inflammatory drugs prescribed in our cou
A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis.
Nivy R, Segev G, Rimer D, Bruchim Y, Aroch I, Mazaki-Tovi M. Nivy R, et al. J Vet Intern Med. 2019 Sep;33(5):2117-2123. doi: 10.1111/jvim.15594. Epub 2019 Aug 10. J Vet Intern Med. 2019. PMID: 31400046 Free PMC article.
Robust treatment recommendations to prevent its recurrence are scarce. OBJECTIVES: To evaluate meloxicam treatment for prevention of clinical recrudescence in male cats with obstructive FIC. ...No difference in the cumulative incidence of UO within 6 months was detected wi …
Robust treatment recommendations to prevent its recurrence are scarce. OBJECTIVES: To evaluate meloxicam treatment for prevention of …
IV meloxicam (Anjeso) for pain.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 29;62(1601):100-102. Med Lett Drugs Ther. 2020. PMID: 32724022 No abstract available.
Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain.
Blair HA. Blair HA. Drugs. 2021 Jul;81(10):1203-1211. doi: 10.1007/s40265-021-01551-9. Epub 2021 Jul 6. Drugs. 2021. PMID: 34228280 Review.
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter referred to as bupivacaine/meloxicam PR; Zynrelef()) is a synergistic fixed-dose combination (FDC) of the local anaesthetic bupivacai …
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter …
2,520 results